Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions

  title={Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions},
  author={Pinchas Halpern and Jenny Moskovich and Beni Avrahami and Yedidia Bentur and Dror Soffer and Kobi Peleg},
  journal={Human \& Experimental Toxicology},
  pages={259 - 266}
Methods: We conducted a prospective, representative-sample nationwide study on morbidity related to 3,4, methylenedioxymethamphetamine (MDMA; ‘ecstasy’) as determined from admissions to 5 geographically representative emergency departments (EDs) and from data from the poison information center (PIC). MDMArelated ED admissions were analyzed over a 7-month period and the records of all PIC calls were reviewed. Results: There were 52 (age 15—44 years, 32 males) ecstasy-related ED admissions during… 

Figures and Tables from this paper

MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017

This large multicentre series of MDMA presentations to EDs showed geographical variation and changes in time trends and in patient demographics, which will enable a greater understanding of the public health implications of MDMA use in Europe.

Safety pharmacology of acute MDMA administration in healthy subjects

MDMA administration was overall safe in physically and psychiatrically healthy subjects and in a medical setting, however, the risks of MDMA are likely higher in patients with cardiovascular disease and remain to be investigated in Patients with psychiatric disorders.

Pattern of Clinical and Toxicological Presentation of Amphetamine Derivative-Methylenedioxymeth-amphetamine Use and its Fatal Outcome in Adolescents and Young Adults in Riyadh, Saudi Arabia

The profile of the designer drug users and summarize the clinical and toxicological information associated with its use in adolescents and young adults besides exploring its fatality over the course of two years for assessing its clinical course and outcome are described.

Mass Gathering Medicine at raves: Incidents and substance-related emergencies

Unique data from the Netherlands demonstrate a very low number of serious health related short-term problems during raves, and experience of health related problems during house parties in the Netherlands is demonstrated.

Environment Influencing Serotonin Syndrome Induced by Ecstasy Abuse.

Ecstasy is a recreational drug containing 3,4-methylenedioxymethamphetamine (MDMA). In the U.S., there are several millions of lifetime users, and millions each year added to the list as new users.

Harm reduction behaviors among polysubstance users who consume ecstasy: can they reduce the negative consequences? An exploratory study

Abstract People who use ecstasy and other drugs recreationally adopt strategies to minimize drug-related negative consequences. However, there are no studies that empirically analyze which strategies

MDMA interactions with pharmaceuticals and drugs of abuse

This article provides an overview of the MDMA-DIs with pharmaceuticals and drugs of abuse and points out the relevance of MDMA-DI’s when MDMA is co-administered with Pharmaceuticals that are metabolized by the CYP2D6 due to MDMA inhibitory action.

Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review

Nine patients who presented after ingesting various forms of MDMA at “rave” music events were found to be hyperthermic in the field with a maximum core body temperature of 109 degrees Fahrenheit and intervention with dantrolene and cooling measures appeared to have no effect on reducing the risk of developing end-organ damage in this patient population.



"Saturday night fever": ecstasy related problems in a London accident and emergency department.

For young adults presenting late at night at weekends and exhibiting symptoms of sympathetic overactivity, disturbed behaviour, and increased temperature ("Saturday night fever") the use of stimulant dance drugs especially MDMA should be suspected.

Ecstasy (MDMA) deaths in New York City: a case series and review of the literature.

All deaths investigated by the OCME that tested positive for MDMA between January 1997 and June 2000 were reviewed and evidence of recent opiate and/or cocaine use was found in 7 of the acute intoxication deaths and in none of the traumatic or combination natural/intoxication deaths.

Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002

This is the largest sample of ecstasy related deaths so far; possible explanations are given for the observed steady increase in ecstasy‐related deaths and a tentative ‘rationale’ for this polypharmacy combination is then proposed.

[Analysis of patients attended in an emergency department due to ecstasy consumption].

Ecstasy consumption generates common attendance at the Emergency Department and can be potentially fatal.

The Epidemiology of Ecstasy Use and Harms in Australia

Messages and interventions to reduce the risks associated with polydrug use and patterns of extended periods of use are clearly warranted and should be delivered outside of traditional health care settings.

Methamphetamine abuse and emergency department utilization.

There was a significant association between trauma and MAP use in this patient population and the data suggest MAP users utilize prehospital and hospital resources at levels higher than the average ED population.

Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

A young woman who suffered serious but reversible toxic reactions from a recreational dose of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and whose blood levels of MDMA were much higher than in any of the fatalities reported by Dowling et al.

Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study

It is found that drug consumption levels were substantial in this “rave” population, particularly with respect to recent use of MDMA, amphetamine, cannabis, and alcohol.

‘Ecstasy’ intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting

The increase in life-threatening episodes of 3,4-methylenedioxymethamphetamine intoxication that mandate admission, treatment and close surveillance in an intensive care milieu make it incumbent to establish appropriate management protocols for minimizing immediate mortality and late morbidity.

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")